Back to results
US 9,790,260 B2Granted
Vaccine for tumor immunotherapy
AssigneeWerner Lubitz
InventorWerner Lubitz
Life of this patent
Estimating the term…
Abstract
The present invention relates to a vaccine comprising dendritic cells and bacterial ghosts for tumor immunotherapy.
Claims24
A composition comprising:
- (i) antigen-presenting cells;
- (ii) at least one tumor cell lysate;
- and,
- (iii) bacterial ghosts from E. coli Nissle 1917.
1 more element
A therapeutic vaccine comprising:
- (i) antigen-presenting cells;
- (ii) at least one tumor cell lysate;
- (iii) bacterial ghosts from E. coli Nissle 1917;
- and
- (iv) a pharmaceutically acceptable carrier or excipient.
2 more elements
A method of treating cancer in a patient comprising:
- administering to the patient a therapeutic vaccine composition comprising
- (i) antigen-presenting cells;
- (ii) at least one tumor cell lysate;
- (iii) bacterial ghosts from E. coli Nissle 1917;
- and
- (iv) a pharmaceutically acceptable carrier or excipient,
- in an amount effective to treat the cancer in the patient.
4 more elements
Dependencies are inferred from the claim text.